Non-coding RNA repertoires in malignant pleural mesothelioma
- PMID: 26791801
- DOI: 10.1016/j.lungcan.2015.11.002
Non-coding RNA repertoires in malignant pleural mesothelioma
Abstract
Malignant pleural mesothelioma (MPM) is a rare malignancy, with extremely poor survival rates. There are limited treatment options, with no second line standard of care for those who fail first line chemotherapy. Recent advances have been made to characterise the underlying molecular mechanisms of mesothelioma, in the hope of providing new targets for therapy. With the discovery that non-coding regions of our DNA are more than mere junk, the field of research into non-coding RNAs (ncRNAs) has exploded in recent years. Non-coding RNAs have diverse and important roles in a variety of cellular processes, but are also implicated in malignancy. In the following review, we discuss two types of non-coding RNAs, long non-coding RNAs and microRNAs, in terms of their role in the pathogenesis of MPM and their potential as both biomarkers and as therapeutic targets in this disease.
Keywords: Long non-coding RNA; Mesothelioma; MicroRNA; Non-coding RNA; TargomiR.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM).Int J Mol Sci. 2018 Apr 26;19(5):1297. doi: 10.3390/ijms19051297. Int J Mol Sci. 2018. PMID: 29701689 Free PMC article. Review.
-
Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).PLoS One. 2013 Aug 19;8(8):e70940. doi: 10.1371/journal.pone.0070940. eCollection 2013. PLoS One. 2013. PMID: 23976967 Free PMC article.
-
Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.Int J Mol Sci. 2018 Feb 17;19(2):595. doi: 10.3390/ijms19020595. Int J Mol Sci. 2018. PMID: 29462963 Free PMC article. Review.
-
LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential.Crit Rev Oncol Hematol. 2023 Jun;186:104012. doi: 10.1016/j.critrevonc.2023.104012. Epub 2023 Apr 26. Crit Rev Oncol Hematol. 2023. PMID: 37116816 Review.
-
GAS5 long non-coding RNA in malignant pleural mesothelioma.Mol Cancer. 2014 May 23;13:119. doi: 10.1186/1476-4598-13-119. Mol Cancer. 2014. PMID: 24885398 Free PMC article.
Cited by
-
LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.Cell Death Dis. 2018 Jun 18;9(7):722. doi: 10.1038/s41419-018-0759-7. Cell Death Dis. 2018. PMID: 29915311 Free PMC article.
-
Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis.Int J Mol Sci. 2018 Jul 27;19(8):2191. doi: 10.3390/ijms19082191. Int J Mol Sci. 2018. PMID: 30060470 Free PMC article. Review.
-
In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM).Int J Mol Sci. 2018 Apr 26;19(5):1297. doi: 10.3390/ijms19051297. Int J Mol Sci. 2018. PMID: 29701689 Free PMC article. Review.
-
Small RNA-Seq Transcriptome Profiling of Mesothelial and Mesothelioma Cell Lines Revealed microRNA Dysregulation after Exposure to Asbestos-like Fibers.Biomedicines. 2023 Feb 13;11(2):538. doi: 10.3390/biomedicines11020538. Biomedicines. 2023. PMID: 36831074 Free PMC article.
-
Genomics and Epigenetics of Malignant Mesothelioma.High Throughput. 2018 Jul 27;7(3):20. doi: 10.3390/ht7030020. High Throughput. 2018. PMID: 30060501 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
